Literature DB >> 19075583

Disease state, age, sex, and post-mortem time-dependent expression of proteins in AD vs. control frontal cortex brain samples.

T Müller1, K Jung, A Ullrich, A Schrötter, H E Meyer, C Stephan, R Egensperger, K Marcus.   

Abstract

Human post-mortem brain samples are excellent source material for the analysis of age-related disorders such as Alzheimer's disease (AD). Moreover, data obtained from cell culture- or mouse model-related experiments often need to be validated by using human tissue. In a variety of studies over the last few years, a huge list of genes or proteins with differential expression or abundance between AD-related and control tissue has been reported. However, highly important issues such as changes in post-mortem time, sex, age etc. of the patients have been rarely included in the analysis. In our study we examined human frontal brain samples of 10 AD patients vs. 10 unaffected controls using state-of-the-art two dimensional DIGE proteomics in order to analyze protein expression of up to 10,000 proteins in parallel. Data were analyzed using well established DIGE-software tool as well as an analysis of covariance model including the factor effects of group and sex and the covariable effects of age and post-mortem time. Within this study we report protein expression changes in AD vs. control human frontal brain samples without any influence of other parameters as well as expression changes depending on the parameters mentioned above. In fact, some proteins previously suggested a state of being dysregulated in AD vs. controls revealed age or sex-dependent regulation. Our analysis suggests the necessity of integrating additionally available covariables in comparative proteome studies of two different sets of human tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075583     DOI: 10.2174/156720508786898488

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  7 in total

Review 1.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

2.  A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle.

Authors:  Maria Zellner; Rita Babeluk; Lene H Jakobsen; Christopher Gerner; Ellen Umlauf; Ivo Volf; Erich Roth; Jens Kondrup
Journal:  J Neural Transm (Vienna)       Date:  2011-03-20       Impact factor: 3.575

Review 3.  Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Authors:  Guillermo Moya-Alvarado; Noga Gershoni-Emek; Eran Perlson; Francisca C Bronfman
Journal:  Mol Cell Proteomics       Date:  2015-12-11       Impact factor: 5.911

Review 4.  Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling.

Authors:  Sunil S Adav; Siu Kwan Sze
Journal:  Mol Brain       Date:  2016-11-03       Impact factor: 4.041

5.  Brain site-specific proteome changes in aging-related dementia.

Authors:  Arulmani Manavalan; Manisha Mishra; Lin Feng; Siu Kwan Sze; Hiroyasu Akatsu; Klaus Heese
Journal:  Exp Mol Med       Date:  2013-09-06       Impact factor: 8.718

6.  Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease.

Authors:  Masakazu Hashimoto; Nenad Bogdanovic; Hiroyuki Nakagawa; Inga Volkmann; Mikio Aoki; Bengt Winblad; Jun Sakai; Lars O Tjernberg
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

7.  Alzheimer's disease: are blood and brain markers related? A systematic review.

Authors:  Ali T Khan; Richard J B Dobson; Martina Sattlecker; Steven J Kiddle
Journal:  Ann Clin Transl Neurol       Date:  2016-05-11       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.